Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ascletis Pharma Inc.

www.ascletis.com

Latest From Ascletis Pharma Inc.

Asia Executives On The Move: Sanofi, GSK, Merck

The coming of spring has brought with it a plethora of pharma executives changes in the Asia Pacific. Sanofi has a new China GM, Merck China R&D head leaves for a startup and Daiichi Sankyo has a new head for its generics business.

Commercial Appointments

Venture Funding Deals: Spin-Outs From Axovant, Inovio & Sosei

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharmaceutical companies that have received venture funding. This month’s column covers deals announced January and February 2019.

Deals Financing

Asia Deal Watch: Bharat Expands Its Vaccine Holdings By Buying GSK’s Chiron Behring

Bharat hopes to expand international reach of Chiron Behring’s rabies vaccine. WuXi and Biolingus partner on sublingual delivery.

Commercial Deals

Tough Going Forces Chinese Biotechs To Form Domestic Alliances

Deals among domestic Chinese biotechs are growing fast, reflecting a need to huddle up amid tightening scrutiny over biotech deal-making and an unusually competitive immuno-oncology market.

Deals Research and Development Strategies
See All

Company Information

  • Industry
  • Biotechnology
    • Antisense, Oligonucleotides
    • Large Molecule
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Hepatic (Liver)
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • China
  • Parent & Subsidiaries
  • Ascletis Pharma Inc.
  • Senior Management
  • Jinzi J Wu, PhD, Pres. & CEO
    Yuemei Yan, VP, Sales
    Zhengqing Li, PhD, CMO
  • Contact Info
  • Ascletis Pharma Inc.
    Phone: 571- 8538-9729
    1785 Jianghai Rd., Bldg. 4, Ste. 1801
    Hangzhou, NC
    China
Advertisement
Advertisement
UsernamePublicRestriction

Register